218. Alport syndrome Clinical trials / Disease details
Clinical trials : 30 / Drugs : 36 - (DrugBank : 15) / Drug target genes : 8 - Drug target pathways : 46
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000036550 | 2020-09-01 | 2020-08-24 | Enzyme-linked immunosorbent determination of urine IV collagen alpha chain early warning value for Alport syndrome | Enzyme-linked immunosorbent determination of urine IV collagen alpha chain early warning value for Alport syndrome | Alport syndrome | Gold Standard:Renal biopsy, skin biopsy and genetic test.;Index test:urine IV collagen a chain test; | Children's Hospital of Shanghai | NULL | Recruiting | 0 | 18 | Both | Target condition:60;Difficult condition:70 | China |